News
Neurologist Dr. Leah Croll talks about the new research suggesting they might help in treating people with alcohol use ...
You may have heard of "Ozempic face" and "Ozempic butt." Well, now there's "Ozempic mouth" and "Ozempic feet" to describe ...
Nationally representative survey data revealed that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) use for obesity ...
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
According to a recent Kaiser Family Foundation poll, roughly 6% of U.S. adults are currently taking GLP-1 for weight loss, ...
A Comprehensive Review of MEDVi’s Personalized GLP-1 Weight Loss Solutions Featuring Affordable Compounded Semaglutide and Tirzepatide Delivered via TelehealthNew York, May 10, 2025 (GLOBE NEWSWIRE) - ...
4d
Civic Science on MSNGLP-1 Trends by CivicScience: Costs Emerge as a Barrier Amid Uncertainty, But Emotional Wellbeing ImprovesThis is just a tiny glimpse of the data available to CivicScience clients. Discover more data. CivicScience has data on more ...
The disconnect between traditional diet products and what GLP-1 users need requires fresh industry thinking. Uncover ...
1d
Us Weekly on MSNThe federal ban on generic GLP-1 starts this month. Here's what you can doIf you're following the GLP-1 (Ozempic and other prescription weight-loss medications) scene, you may have read that the FDA ...
The rise in GLP-1 use among young women raises concerns about contraceptive efficacy and potential pregnancy risks. Learn ...
The use of GLP-1s among patients with type 2 diabetes appeared associated with significantly reduced risk for certain ...
Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results